![]() |
市场调查报告书
商品编码
1755891
2032 年鲔鱼胜肽市场预测:按类型、来源、提取流程、分销管道、应用和地区进行的全球分析Tuna Peptides Market Forecasts to 2032 - Global Analysis By Type (Powder and Liquid), Source (Skipjack Tuna, Yellowfin Tuna, Albacore Tuna, Bluefin Tuna and Other Sources), Extraction Process, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,全球鲔鱼胜肽市场预计在 2025 年达到 10.3 亿美元,到 2032 年将达到 13.6 亿美元,预测期内的复合年增长率为 6.7%。
鲔鱼胜肽是透过酵素水解鲔鱼获得的生物活性蛋白片段,为各行各业带来健康益处。这些胜肽具有抗氧化、抗发炎和增强免疫力的功效,在营养保健品、机能性食品和药品中具有重要价值。其高生物利用度有助于肌肉恢復、认知健康和代谢调节。此外,鲔鱼胜肽还具有活肤功效,因此可作为化妆品和个人护理产品的主要成分。
机能性食品和膳食补充剂的需求不断增加
消费者越来越关注能够促进整体健康的生物活性成分,这推动了富含蛋白质的胜肽市场的成长。鲔鱼胜肽具有抗氧化、抗发炎和促进代谢的特性,使其成为膳食补充剂和强化食品的理想选择。此外,人们对海洋衍生健康解决方案的认识不断提高,也推动了胜肽製剂的创新。个人化营养的普及进一步增强了鲔鱼衍生生物活性化合物在健康消费中的作用。
生产加工成本高
酵素的萃取和精製过程需要复杂的技术和专业知识,这增加了生产成本。此外,采购用于胜肽生产的永续鲔鱼需要严格的资源管理,这会影响原料成本。纯度、安全性和有效性方面的监管合规性增加了产品开发的复杂性,影响了定价策略,并阻碍了市场成长。
进一步研究生物活性特性与新应用
持续的研究探讨海洋胜肽对心血管、神经和代谢的益处,为其在药物和膳食补充剂中的应用开闢了新的途径。此外,化妆品和运动营养领域的配方创新正在推动市场多元化。鲔鱼胜肽被纳入蛋白棒、食品饮料和替代食品等机能性食品类别,进一步推动了该产业的扩张。
关于捕鱼活动和污染物的负面通报
与过度捕捞和生态系统破坏相关的永续性问题影响着消费者的认知,并导致对采购惯例的监管日益严格。海洋原料的重金属污染带来了监管挑战,需要采取严格的品管措施。重视道德和可追溯供应链的公司可以降低声誉风险并确保生产透明度。
疫情使消费者的兴趣转向免疫健康和蛋白质补充,这也影响了鲔鱼胜肽市场。人们对健康功能性成分的认识不断提高,推动了膳食补充剂中对生物活性胜肽的需求。然而,供应链中断影响了原料采购和生产效率,导致产量暂时波动。在復苏阶段,对海洋基膳食补充剂解决方案的投资增加,以满足消费者对天然、科学认证产品的偏好。
酶水解细分市场预计将成为预测期内最大的细分市场
酶水解技术预计将在预测期内占据最大的市场占有率,因为它能够高效生产高纯度的生物活性胜肽。此方法能够更好地控制分子量分布,从而获得适用于食品、膳食补充剂和药物应用的理想功能特性。对氨基酸谱清晰的蛋白质成分的需求日益增长,进一步推动了该过程的普及。
预计膳食补充剂领域在预测期内将出现最高的复合年增长率。
在预测期内,由于消费者对预防性健康和积极生活方式的意识不断增强,膳食补充剂行业预计将呈现最高增长率。鲔鱼胜肽越来越多地被应用于蛋白粉、胶囊和机能饮料中,以促进肌肉恢復、能量和代谢健康。随着消费者从合成补充剂转向天然海洋替代品,鲔鱼胜肽等生物可利用的蛋白质来源正日益受到青睐。
在预测期内,亚太地区预计将占据最大的市场占有率,这得益于该地区强劲的海洋产业和日益增长的机能性食品需求。日本、韩国和中国等国家长期以来将鱼贝类蛋白纳入日常饮食,这支撑了市场的熟悉度和接受度。政府为提升海洋生物技术和水产品附加价值所做的努力也促进了该产业的发展。
在预测期内,由于快速的都市化、消费者偏好的变化以及日益增长的健康保健趋势,亚太地区预计将呈现最高的复合年增长率。蛋白质补充剂在印度、印尼和越南等新兴国家越来越受欢迎,带来了新的成长潜力。同时,本地新兴企业和现有企业正在投资研发,利用鲔鱼胜肽开发适合当地需求的产品。
According to Stratistics MRC, the Global Tuna Peptides Market is accounted for $1.03 billion in 2025 and is expected to reach $1.36 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Tuna peptides are bioactive protein fragments derived from enzymatic hydrolysis of tuna, offering health benefits across multiple industries. These peptides exhibit antioxidant, anti-inflammatory, and immune-boosting properties, making them valuable in nutraceuticals, functional foods, and pharmaceuticals. Their high bioavailability supports muscle recovery, cognitive health, and metabolic regulation. Additionally, tuna peptides serve as key ingredients in cosmetics and personal care due to their skin-rejuvenating effects.
Rising demand for functional foods and nutraceuticals
Consumers are increasingly seeking bioactive ingredients that promote overall wellness, boosting market growth for protein-rich peptides. Tuna peptides offer antioxidant, anti-inflammatory, and metabolic benefits, making them ideal for dietary supplements and fortified food products. Additionally, the rising awareness of marine-based health solutions is encouraging innovation in peptide formulations. The expansion of personalized nutrition further strengthens the role of tuna-derived bioactive compounds in health-conscious consumption.
High production and processing costs
The enzymatic extraction and purification process require advanced technology and expertise, increasing manufacturing expenses. Additionally, sourcing sustainable tuna for peptide production demands stringent resource management, impacting raw material costs. Regulatory compliance for purity, safety, and efficacy adds complexity to product development, influencing pricing strategies impeding the market growth.
Further research into bioactive properties and new applications
Continuous studies exploring cardiovascular, neurological, and metabolic benefits of marine peptides are opening new avenues for pharmaceutical and nutraceutical applications. Additionally, formulation innovations in cosmetics and sports nutrition are enhancing market diversification. The integration of tuna peptides in functional food categories such as protein bars, beverages, and meal replacements further supports industry expansion.
Negative publicity related to fishing practices or contaminants
Sustainability issues related to overfishing and ecosystem disruption impact consumer perception, leading to increased scrutiny of sourcing practices. Heavy metal contamination in marine-derived ingredients raises regulatory challenges, requiring stringent quality control measures. Companies emphasizing ethical and traceable supply chains can mitigate reputational risks, ensuring transparency in production
The pandemic influenced the tuna peptides market by shifting consumer focus toward immune health and protein supplementation. Increased awareness of functional ingredients for wellness drove demand for bioactive peptides in dietary supplements. However, supply chain disruptions affected raw material procurement and manufacturing efficiency, leading to temporary fluctuations in production. The recovery phase saw increased investment in marine-based nutraceutical solutions, aligning with consumer preferences for natural and scientifically backed products.
The enzymatic hydrolysis segment is expected to be the largest during the forecast period
The enzymatic hydrolysis segment is expected to account for the largest market share during the forecast period due to its efficiency in producing high-purity bioactive peptides. This method allows for better control over molecular weight distribution, resulting in functional properties ideal for food, nutraceutical, and pharmaceutical applications. The growing demand for protein ingredients with defined amino acid profiles is further boosting the popularity of this process.
The dietary supplements segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dietary supplements segment is predicted to witness the highest growth rate driven by rising consumer awareness around preventive health and active lifestyles. Tuna peptides are being increasingly incorporated into protein powders, capsules, and functional beverages targeting muscle recovery, energy, and metabolic health. As consumers move away from synthetic supplements toward natural, marine-based alternatives, the appeal of bio available protein sources like tuna peptides is growing.
During the forecast period, the Asia Pacific region is expected to hold the largest market share supported by the region's strong marine industry and growing focus on functional foods. Countries such as Japan, South Korea, and China have a long history of incorporating seafood-based proteins into daily diets, which supports market familiarity and acceptance. Government initiatives promoting marine biotechnology and value-added seafood products are also contributing to industry development.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rapid urbanization, evolving consumer preferences, and expanding health & wellness trends. The increasing popularity of protein supplementation in emerging economies like India, Indonesia, and Vietnam is providing new growth avenues. In parallel, regional startups and established players are investing in R&D to develop regionally tailored products using tuna peptides.
Key players in the market
Some of the key players in Tuna Peptides Market include Lonza Group, Glanbia Nutritionals, Cargill, Incorporated, Seagarden AS, Copalis Sea Solutions, Hofseth BioCare ASA, Aker BioMarine Antarctic AS, Biomega Group, Nitta Gelatin Inc., Gelita AG, Vital Proteins LLC, Bluewave Marine Ingredients, NutriScience Innovations LLC, Great Pacific BioProducts Ltd., and Bioiberica S.A.U.
In May 2025, Lonza Group AG Launched Design2Optimize(TM), a model-based API development platform designed to accelerate small-molecule process optimization and shorten clinical timelines
In January 2025, Vital Proteins LLC Expanded into the colostrum category, debuting a new health supplement to broaden its collagen-based wellness portfolio
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.